CSF3 and Alzheimer disease: Interestingly, fast-progressing AD patients display diminished SCF serum concentrations63 and combined sub-cutaneous SCF/G-CSF treatment in APPSWE/PS1L166P mice attenuates cortical and hippocampal Aβ deposition64.